minoxidil has been researched along with Recrudescence in 5 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-two patients with mild to extensive alopecia areata, including 16 patients with alopecia totalis or universalis, entered a randomized, controlled trial of a 6-week taper of prednisone followed by either 2% topical minoxidil or vehicle applied three times daily for an additional 14 weeks." | 9.07 | Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. ( Carson, SC; Olsen, EA; Turney, EA, 1992) |
| "Thirty-two patients with mild to extensive alopecia areata, including 16 patients with alopecia totalis or universalis, entered a randomized, controlled trial of a 6-week taper of prednisone followed by either 2% topical minoxidil or vehicle applied three times daily for an additional 14 weeks." | 5.07 | Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. ( Carson, SC; Olsen, EA; Turney, EA, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Ashmawy, AA | 1 |
| El-Maadawy, IH | 1 |
| El-Maghraby, GM | 1 |
| Alkhalifah, A | 1 |
| Alsantali, A | 1 |
| Wang, E | 1 |
| McElwee, KJ | 1 |
| Shapiro, J | 1 |
| Feldhoff, CM | 1 |
| Bachmann, H | 1 |
| Weidmann, P | 1 |
| Keusch, G | 1 |
| Olsen, EA | 1 |
| Carson, SC | 1 |
| Turney, EA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Combined CO2 Fractional Laser With Bimatoprost 0.03% in Treatment of Alopecia Areata[NCT05600673] | Phase 1/Phase 2 | 30 participants (Actual) | Interventional | 2019-01-01 | Completed | ||
| Efficacy of Fractional CO2 Laser Alone and as Transepidermal Drug Delivery for Different Modalities of Treatment in Alopecia Areata[NCT04003376] | Phase 4 | 40 participants (Anticipated) | Interventional | 2019-07-26 | Recruiting | ||
| Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata[NCT03800979] | Phase 4 | 19 participants (Actual) | Interventional | 2019-01-12 | Completed | ||
| Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease[NCT01981889] | Phase 4 | 53 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Patients came back for follow-up every month during a total of 24 weeks of treatments and at weeks 28,36 and 48. (NCT03800979)
Timeframe: 48 weeks
| Intervention | participants (Number) | ||||||
|---|---|---|---|---|---|---|---|
| Dyslipidemia | Upper respiratory tract infection | Tuberculosis | Myalgia | Acne | Weight gain | Constipation | |
| Tofacitinib | 9 | 6 | 1 | 1 | 2 | 1 | 1 |
2 reviews available for minoxidil and Recrudescence
| Article | Year |
|---|---|
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
[Treatment of therapy-resistant hypertension].
Topics: Adrenergic beta-Antagonists; Diazoxide; Diuretics; Drug Resistance; Drug Therapy, Combination; Human | 1977 |
2 trials available for minoxidil and Recrudescence
| Article | Year |
|---|---|
Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia Areata; Betamethasone | 2018 |
Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Alopecia Areata; Child; Dermatit | 1992 |
1 other study available for minoxidil and Recrudescence
| Article | Year |
|---|---|
[Pericardial effusion during long-term treatment with minoxidil].
Topics: Child; Hemolytic-Uremic Syndrome; Humans; Male; Minoxidil; Pericardial Effusion; Pyrimidines; Recurr | 1982 |